Home › Prostate Cancer › Delaware
Prostate Cancer clinical trials in Delaware
10 studies for Prostate Cancer are looking for participants at sites in Delaware.
Cities in Delaware
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Medical Oncology Hematology Consultants, Newark
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT04585750Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT07200830Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Beebe South Coastal Health Campus, Millville
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06632977A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07213674Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- Christiana Care Health System-Wilmington Hospital, Wilmington
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Beebe Medical Center, Lewes
- Beebe South Coastal Health Campus, Millville
- Helen F Graham Cancer Center, Newark
- and 4 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Beebe Medical Center, Lewes
- Beebe South Coastal Health Campus, Millville
- Helen F Graham Cancer Center, Newark
- and 4 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jan 22, 2026 · NCT06470243Vitamin D for Prostate Endocrine Therapy
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
RecruitingPhase 3
Ages 50 and older · Men · Updated Jan 15, 2026 · NCT05838716SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Newark
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Helen F Graham Cancer Center, Newark
- Christiana Care Health System-Christiana Hospital, Newark
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.